RBC Capital analyst Mitch Steves raised the firm’s price target on Lam Research (LRCX) to $310 from $290 and keeps an Outperform rating on the shares. The company delivered a solid beat and raise, driven by GenAI demand and market share gains, the analyst tells investors in a research note. DRAM memory was particularly strong in a quarter and NAND outlook is also improving, RBC added.
Meet Samuel – Your Personal Investing Prophet
Double your LRCX exposure with Tradr's LRCUPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRCX:
- Lam Research price target raised to $330 from $285 at BofA
- Lam Research price target raised to $340 from $290 at TD Cowen
- Lam Research price target raised to $325 from $300 at Stifel
- Lam Research price target raised to $315 from $300 at Citi
- Lam Research price target raised to $385 from $350 at Susquehanna